Our review underscores the importance of including SOT recipients in trials comparing short versus long antibiotic therapy for GN-BSIs. Although no statistically significant differences were observed between treatment durations, the limited sample size precludes definitive conclusions and highlights the need for larger, high-quality studies.
Alotaibi et al. (2026) studied this question.